WELCOME TO THE DELVE BLOG.

Considering a wearable for your upcoming clinical trial? 

The Apple Watch is an FDA approved Class II device with a slick, beautiful and powerful utility to help conduct a remote virtual clinical trial. 

At Delve Health, we utilize the Apple Watch to collect over 20 digital endpoints across multiple therapeutic areas. Below are a few cases, where an Apple Watch is being used:

  • Enable the early detection of atrial fibrillation and potentially improve outcomes including stroke
  • Identify irregular heart rhythms, including for serious heart conditions such as atrial fibrillation
  • Parkinson’s disease, in which symptoms include tremors, rigidity, slowness of movement and difficulty with walking
  • Monitor symptom variations as a result of changes in medications or deep brain stimulation treatment
  • Step count as a possible prognostic marker in some lung cancer patients
  • Collect 6MWT for patients with clots
  • Measure of blood oxygen saturation, glucose, stress, and blood pressure

Other Uses for the Apple Watch

  • Collect patient reported outcomes questionnaire
  • Collect quality of life questionnaires 
  • Send real-time notifications to study teams for potential adverse events
  • Receive study notifications

Current Apple Watch Model Comparison 

 Series 6SESeries 7
Size 44/4044/4045/41
Display368×448/
324×394
368×448/
324×394
396×484/
352×430
Always-On
x
x
Cellular Option
x
x
x
ECG
x
x
SPO2
x
x
Heart Rate
x
x
x
Fall Detection
x
x
x
Wireless Charging
x
x
x
Full Keyboard
– 
– 
x
Full charge
1.5 hours
2.5 hours
1 hour
Siri
x
x
x
Battery Life
18 Hours
18 Hours
18 Hours
Memory
32GB
32GB
32GB
Colors
Gold, Silver,
Red, Gray,
Blue
Gold,
Gray,
Silver
Red, Blue, 
Green, Black,
Silver
Price
$349.00
$279.00
$399.00
Interested to learn more? Click here to schedule a few minutes to chat with one of our expert.
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

SIMILAR ARTICLES

Delve Health Provides the Technology Platform to Design Clinical Trials to Fit a Patient’s Lifestyle—Not the Other Way Around

A significant number of companies announced delays and cancellations to planned and on-going clinical trials because of COVID-19 lockdowns and social distancing measures. There
real-time outcomes

Remote Patient Monitoring in Clinical Trials

In 1958, AT&T came out with the Bell 101 modem—the first commercial modem to transmit data via what would later be known as “the
Screen Shot Clinical researcher

Opinion: We Have Been Gifted a New Outlook on Increasing Patient Diversity, Compliance, and Retention in Clinical Trials

ACRP Clinical Researcher—June 21, 2022 Our own co-founder and CEO of Delve Health, Wessam Sonbol was published in the ACRP Clinical Researcher magazine. The
Patient Reported Outcomes

Conversations On the Ground—Traditional CROs vs. Virtual CROs

Delve Health’s upper management is currently attending the Drug Information Association’s (DIA) 2022 Global Annual Meeting in Chicago, Illinois. While we are taking all
Screen Shot afortiori development

Delve Health and Afortiori Development Announced Their Collaboration. What Does it Mean for Clinical Research?

Delve Health, a clinical research technology firm, and Afortiori Development, a clinical contract research organization (CRO), have announced an exciting partnership to expand patient
clinical trail day screenshot

Clinical Trials Day

May 20, 2022—Today is Clinical Trials Day. A day to recognize and raise awareness as to why clinical trials are so important to all
Previous
Next